What Is TELA Bio, Inc. (TELA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for TELA Bio, Inc.. Trading at $0.75 against an estimated intrinsic value of $1.56, 9 of 11 active models flag meaningful upside of +108.3% on average. The most optimistic model, EPV, places fair value at $3.39 (+351.5%), while Bayesian DCF — the most conservative — estimates $0.02 (-97.7%). This +449.2% gap reflects genuine analytical uncertainty about TELA Bio, Inc.'s intrinsic worth.
What Do the Models Say About TELA?
11 of 13 models are currently active for TELA. Of these, 9 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates TELA's intrinsic value at $0.02, implying -97.7% downside from the current price. See which stocks rank higher →
How Does TELA Rank in Surgical & Medical Instruments & Apparatus?
Among 117 Surgical & Medical Instruments & Apparatus stocks, TELA ranks #54 by Quality of Company score. CirclFi's QOC score of 6.7/10 evaluates 32 fundamental signals. A score of 6.7 indicates above-average quality.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
TELA Bio, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is TELA a Value Trap?
CirclFi's Value Trap algorithm assigns TELA a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for TELA Bio, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, TELA Bio, Inc. scores 6.7 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +449.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every TELA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across TELA's 11 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad